Supplementary Figure 5 from Reducing TNF Receptor 2+ Regulatory T Cells via the Combined Action of Azacitidine and the HDAC Inhibitor, Panobinostat for Clinical Benefit in Acute Myeloid Leukemia Patients

Authors :: Magdalena Plebanski
Andrew Spencer
Andrew Wei
Patricia Walker
Peter Tan
Chindu Govindaraj
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 1448K, The proportion of TNFR2- and TNFR2+ effector T cells between healthy and AML patients.

Full Text Access

Tools